Aim and objective: To study the prevalence of sleep disorders in patients with moderate and severe types of allergic rhinitis (AR). Materials and methods: Patients presenting to the ENT OPD of a tertiary care hospital were evaluated using validated tools. Those with symptoms of allergic rhinitis and having a score of >7 using the score for allergic rhinitis (SFAR) questionnaire, were assessed for severity of allergic rhinitis using allergic rhinitis and its impact on asthma (ARIA) classification. A total of 210 patients with moderate to severe AR were included. Associated sleep disorders were assessed using self-administered questionnaires—French version (HD 42) and Epworth sleepiness scale score (ESS). The data was compiled into IBM SPSS statistics 2.0 windows and correlated. Results: Among 210 patients included in this study, the sleep disorders reported were insomnia in 59%, hypersomnia in 38.6%, and obstructive sleep apnea (OSA) in 2.4% with no gender or age significance (p = 0.153 and 0.173, respectively). A total of 83.3% of patients complained of tiredness on waking up in the morning and 54.3% of patients reported daytime somnolence. Snoring was correlated with OSA and was seen to be higher in males (45%, p = 0.001) and middle aged (42.96 years, p = 0.002). Conclusion: There is a significant prevalence of sleep disorders in patients with moderate to severe allergic rhinitis. Early detection and treatment of these will improve their quality of life. Clinical significance: Patients presenting with AR symptoms should be routinely questioned about their sleep quality and daytime somnolence so that early detection and aggressive treatment of AR can help in controlling the resultant sleep disturbances and thereby significantly improve the quality of life in these individuals.
Scadding G, Durham S, et al. Allergic rhinitis. In: Gleeson M (ed.), Scott Brown's Otorhinolaryngology and Head and Neck Surgery, 7th edition. Great Britain: Hodder Arnold; 2008. pp 1386–1407.
Galera H, Colas C, Añibarro B, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy 2012;42(7):1080–1087. DOI: 10.1111/j.1365-2222.2011.03935.x.
Annesi-Maesano I, Didier A, Klossek M, et al. The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 2002;57(2):107–114. DOI: 10.1034/j.1398-9995.2002.1o3170.x.
Bouquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and Allergen).Allergy 2008;63(Suppl 86):8–160. DOI: 10.1111/j.1398-9995.2007.01620.x.
Leger D, Bonnefoy B, Pigearias B, et al. Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children. Allergy Asthma Clin Immunol 2017;13:36. DOI: 10.1186/s13223-017-0208-7.
Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes. World Psychiatry 2013;12(2):92–98. DOI: 10.1002/wps.20050.
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest 2014;146(5):1387–1394. DOI: 10.1378/chest.14-0970.
Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med 2006;166(16):1744–1748. DOI: 10.1001/archinte.166.16.1744.
Rimmer J, Downie S, Bartlett DJ, et al. Sleep disturbance in persistent allergic rhinitis measured using actigraphy. Ann Allergy Asthma Immunol 2009;103(3):190–194. DOI: 10.1016/S1081-1206(10)60180-9.
Cano RM, Ribó P, Araujo G, et al. Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort. Clin Transl Allergy [Internet] 2018;8:23. DOI:10.1186/s13601-018-0212-0.
Stuck BA, Czajkowski J, Hagner A, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004;113(4):663–668. DOI: 10.1016/j.jaci.2003.12.589.
Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 2002;32(9):1310–1315. DOI: 10.1046/j.1365-2745.2002.01483.x.
Gadi G, Wali S, Koshak E, et al. The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea. J Epidemiol Glob Health [Internet] 2017;7(1):37–44. DOI: 10.1016/j.jegh.2016.06.001.
Kramer MF, Chaux RDELA, Dreher A, et al. Allergic rhinitis does not constitute a risk factor for obstructive sleep. Acta Otolaryngol 2001;121(4):494–499.
Craig TJ, Mende C, Hughes K, et al. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc 2003:24(1):53–58.
Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy [Internet] 2003;58(5):380–385. DOI: 10.1034/j.1398-9995.2003.00093.x.
Potter PC, Van Niekerk CH, Schoeman HS, et al. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol 2003;91(4):368–374. DOI: 10.1016/S1081-1206(10)61684-5.